Intellectual property rights

Intellectual Property Rights

Item	Description
Policy / Commitment	Intellectual property rights (patents / trademarks) are aligned with the Company’s product R&D and innovation.
Commitment	1. Intellectual property rights (patents) meet established targets.
Commitment	2. Intellectual property rights (trademarks) meet established targets.
Short-term Goal	Continuously maintain matters related to intellectual property rights.
Medium- to Long-term Goal	Continuous product development; patent and trademark R&D that meets the requirements of industry clients.
Resources Invested / Concrete Outcomes	1. Pharmaceuticals
	2024: SR-T100 injection repeated toxicity studies in rodent and non-rodent animals (GLP), and SR-T100 injection Pre-IND consultation application.
	2. Food products
	2023: Development of eye-care product (利保晶).
	3. Cosmetics
	2024: SR-100 秒舒脈 cream.

	1. Patents
	1. Patents for wart treatment
	▲ 1 invention patent in Taiwan
	▲ 16 foreign invention patents
	2. Patents related to photodamage and photoprotection
	▲ 1 invention patent in Taiwan
	▲ 15 foreign invention patents
	2. Trademarks
	1. Domestic (Taiwan)
	▲ 16 trademark designs
	2. Overseas (United States, European Union, United Kingdom, Japan, Vietnam, China)
	▲ 7 trademark designs

※ On mobile devices, you can swipe horizontally to view all table columns; on desktop, the full width is displayed without truncation.

Status / Year	2022	2023	2024
Granted	33	33	33
Pending	1	1	1

Note: During 2022–2024, the number of R&D patent cases remained relatively flat.

Status / Year	2022	2023	2024
Granted	21	26	23
Pending	1	3	0

Note: During 2022–2024, the number of granted intellectual property rights (trademarks) showed an upward trend.

※ On mobile devices, you can swipe horizontally to view all table columns; on desktop, the full width is displayed without truncation.

Line